Disease | melanoma, malignant |
Comorbidity | C0042900|vitiligo |
Sentences | 13 |
PubMedID- 22908963 | Serum dppiv activity in healthy controls (c), in people with vitiligo (v), in patients with melanoma (m), and in patients with other malignant skin tumors (mst) or benign skin changes (bs). |
PubMedID- 25834362 | However, the prognostic value of vitiligo in melanoma was reported to be inconsistent among previous reports. |
PubMedID- 25605840 | vitiligo-like depigmentation in patients with stage iii-iv melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. |
PubMedID- 23136900 | Recent genetic studies suggest a lower susceptibility to melanoma in patients with vitiligo; however, lifetime melanoma prevalence in patients with vitiligo has not previously been studied. |
PubMedID- 21794122 | The occurrence of vitiligo in melanoma patients undergoing immunotherapy may be due to both qualitative and quantitative differences between the cd8+ t cells in the two diseases. |
PubMedID- 25242557 | Objective: we sought to study the relative risk (rr) of melanoma and nmsc in patients with vitiligo compared with that in patients seen for vascular surgery. |
PubMedID- 25702668 | Association of vitiligo and response in patients with metastatic malignant melanoma on temozolomide. |
PubMedID- 24366614 | Additionally, association of vitiligo with immunotherapy of melanoma employing activated cytotoxic t cells specific for shared tumor antigens and melanosomal proteins further supports the autoimmune etiology of vitiligo(mehrotra et al., 2012; sakai et al., 1997; yee et al., 2000). |
PubMedID- 22561518 | The associated region contains 20 genes, notably including mc1r, encoding the melanocortin receptor, a regulator of melanogenesis and minor vitiligo autoantigen, associated with malignant melanoma and with skin and hair color20. |
PubMedID- 23887251 | Cutaneous vitiligo following management of uveal melanoma in 6 patients. |
PubMedID- 24082190 | The occurrence of vitiligo like lesions in patients with metastatic melanoma in comparison has a better prognosis. |
PubMedID- 20498710 | Successful melanoma immunotherapy can lead to treatment-related vitiligo-like leukoderma as an autoimmune side-effect [18], which is considered an encouraging prognostic sign [19], [20]. |
PubMedID- 21909283 | Waardenburg syndromes), differentiation (albinism), survival (vitiligo) or control of proliferation (melanoma) [6]. |
Page: 1